An open trial to assess the tolerability of AVANZ Olive immunotherapy [Ensayo abierto para evaluar la tolerabilidad de la inmunoterapia con AVANZ Olivo]

Trial Profile

An open trial to assess the tolerability of AVANZ Olive immunotherapy [Ensayo abierto para evaluar la tolerabilidad de la inmunoterapia con AVANZ Olivo]

Completed
Phase of Trial: Phase II/III

Latest Information Update: 29 Apr 2013

At a glance

  • Drugs Olea pollen allergy immunotherapy (Primary)
  • Indications Allergic rhinoconjunctivitis; Asthma
  • Focus Adverse reactions
  • Most Recent Events

    • 01 Apr 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 28 Aug 2012 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health; NCT01674595).
    • 28 Aug 2012 Planned End Date changed from 10 Oct 2012 to 1 Apr 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top